COSMO PHARM N news, videos and press releases - Page 2
For more news please use our advanced search feature.
COSMO PHARM N - More news...
COSMO PHARM N - More news...
- COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW(R) TO ALL COUNTRIES EXCEPT CANADA
- COSMO ANNOUNCES FULL-YEAR RESULTS 2021; CONFIRMS BEATING GUIDANCE
- First U.S. trial using GI Genius(TM) intelligent endoscopy module shows 50% reduction in missed colorectal polyps with Artificial Intelligence (AI) technology versus standard colonoscopy
- Invitation to Cosmo's full-year 2021 results and 2022 outlook webcast presentation on 23 March 2022
- Cosmo Pharmaceuticals Announces 2021 preliminary results beating guidance, return to dividend distribution AND 2022 guidance
- EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A ANNOUNCE SETTLEMENT OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES IN CASSIOPEA S.P.A.
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A.
- EQS-News: DETECT study shows AI assistance using GI Genius(TM) reduces missed polyp rate by nearly 50% on initial colonoscopy
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. AND DECLARE THE OFFER SUCCESSFUL
- EQS-Adhoc: Cosmo announces regulatory approval of GI Genius(TM) in Canada
- EQS-Adhoc: Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Extraordinary General Meeting
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH PROVISIONAL INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.
- EQS-Adhoc: COSMO PHARMACEUTICALS N.V. LAUNCHES PUBLIC EXCHANGE OFFER TO ACQUIRE CASSIOPEA S.P.A.
- EQS-Adhoc: Cosmo Half-Year Report 2021
- EQS-Adhoc: Cosmo Pharmaceuticals Announces Cassiopea SpA's Signing of License and Supply Agreements for Winlevi(R) in US and Canada
- EQS-Adhoc: Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Annual General Meeting
- EQS-Adhoc: Cosmo Pharmaceuticals announces a change in its board of directors
- EQS-Adhoc: Cosmo announces the start of trading of its shares on XETRA
- EQS-Adhoc: Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
- EQS-Adhoc: Cosmo Full-Year Report 2020: Cosmo returns to operating profit
